310 related articles for article (PubMed ID: 2888144)
1. [Neuroleptic modification of basic schizophrenic disorders].
Heim M; Morgner J
Psychiatr Neurol Med Psychol (Leipz); 1987 May; 39(5):274-80. PubMed ID: 2888144
[TBL] [Abstract][Full Text] [Related]
2. [Value of neuroleptic therapy in the self assessment of schizophrenic patients].
Heim M
Psychiatr Neurol Med Psychol (Leipz); 1987 Aug; 39(8):487-91. PubMed ID: 3685210
[TBL] [Abstract][Full Text] [Related]
3. [Changes in the health state of schizophrenic patients in neuroleptic therapy].
Heim M
Psychiatr Neurol Med Psychol (Leipz); 1986 Aug; 38(8):483-7. PubMed ID: 2878452
[TBL] [Abstract][Full Text] [Related]
4. [Quality of life of schizophrenic patients and clozapine].
Raoul Y; Manesse P; Delage M
Encephale; 1997 Sep; 23 Spec No 4():12-6. PubMed ID: 9417398
[TBL] [Abstract][Full Text] [Related]
5. Clozapine maintenance therapy in schizophrenia.
Gaszner P; Makkos Z
Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):465-9. PubMed ID: 15093952
[TBL] [Abstract][Full Text] [Related]
6. Treatment of clozapine-associated tardive dyskinesia.
Lin CC; Bai YM; Chen JY; Wang YC; Liou YJ
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):599-600. PubMed ID: 17920744
[No Abstract] [Full Text] [Related]
7. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.
Szymanski S; Lieberman J; Pollack S; Kane JM; Safferman A; Munne R; Umbricht D; Woerner M; Masiar S; Kronig M
Biol Psychiatry; 1996 Feb; 39(4):249-54. PubMed ID: 8645771
[TBL] [Abstract][Full Text] [Related]
8. Neuroleptic-induced emesis: a new indication for clozapine?
Bustillo JR; Buchanan RW
Biol Psychiatry; 1995 Aug; 38(3):194-5. PubMed ID: 7578665
[No Abstract] [Full Text] [Related]
9. [Use and value of the therapeutic neuroleptic-bromocriptine combination in schizophrenia].
Lombertie ER; Durelle G; Fuseau A
Ann Med Psychol (Paris); 1995 Oct; 153(8):531-4. PubMed ID: 8561400
[TBL] [Abstract][Full Text] [Related]
10. Neuroleptic withdrawal in patients meeting criteria for supersensitivity psychosis.
Singh H; Hunt JI; Vitiello B; Simpson GM
J Clin Psychiatry; 1990 Aug; 51(8):319-21. PubMed ID: 1974249
[TBL] [Abstract][Full Text] [Related]
11. Pimozide augmentation for the treatment of schizophrenic patients who are partial responders to clozapine.
Friedman J; Ault K; Powchik P
Biol Psychiatry; 1997 Sep; 42(6):522-3. PubMed ID: 9285089
[No Abstract] [Full Text] [Related]
12. [Treatment of schizophrenia from the viewpoint of the patient. Studies on the course of treatment and neuroleptic treatment from a personal perspective].
Windgassen K
Monogr Gesamtgeb Psychiatr Psychiatry Ser; 1989; 58():1-169. PubMed ID: 2576099
[No Abstract] [Full Text] [Related]
13. Negative correlation between alpha-1-acid-glycoprotein plasma level and response to haloperidol in the acute treatment of schizophrenia.
Levinson I; Levine S
Biol Psychiatry; 1995 Aug; 38(3):198-200. PubMed ID: 7578667
[No Abstract] [Full Text] [Related]
14. Schizophrenia and severe tardive dyskinesia responsive to risperidone.
Kopala LC; Honer WG
J Clin Psychopharmacol; 1994 Dec; 14(6):430-1. PubMed ID: 7533794
[No Abstract] [Full Text] [Related]
15. [Schizophrenically disordered time perception and its modification by neuroleptics].
Heim M; Morgner J
Psychiatr Neurol Med Psychol (Leipz); 1985 Jul; 37(7):410-5. PubMed ID: 4048304
[TBL] [Abstract][Full Text] [Related]
16. [Schizophrenic deficit syndrome and neurologic tolerance].
Verdoux H; Bourgeois M
Encephale; 1996 Jun; 22 Spec No 2():45-7. PubMed ID: 8767042
[TBL] [Abstract][Full Text] [Related]
17. Depressive symptoms and schizophrenia a psychopharmacological approach.
Mauri MC; Bravin S; Fabiano L; Vanni S; Boscati L; Invernizzi G
Encephale; 1995; 21(5):555-8. PubMed ID: 8529564
[TBL] [Abstract][Full Text] [Related]
18. ICI 204,636: a new atypical antipsychotic drug.
Hirsch SR; Link CG; Goldstein JM; Arvanitis LA
Br J Psychiatry Suppl; 1996 May; (29):45-56. PubMed ID: 8733823
[No Abstract] [Full Text] [Related]
19. The effect of attention/information processing impairment of tardive dyskinesia and neuroleptics in chronic schizophrenics.
Spohn HE; Coyne L
Brain Cogn; 1993 Sep; 23(1):28-39. PubMed ID: 8105820
[TBL] [Abstract][Full Text] [Related]
20. [Weight gain and clozapine].
Jalenques I; Tauveron I; Albuisson E; Audy V
Encephale; 1996 Oct; 22 Spec No 3():77-9. PubMed ID: 8954282
[No Abstract] [Full Text] [Related]
[Next] [New Search]
